Determination of gouty arthritis' biomarkers in human urine using reversed-phase high-performance liquid chromatography  by Xiang, Lei-Wen et al.
Contents lists available at ScienceDirect
www.elsevier.com/locate/jpa
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis 2014;4(2):153–1582095-1779 & 2014 Xi
http://dx.doi.org/10.10
nCorresponding aut
E-mail address: lih
Peer review under rwww.sciencedirect.comORIGINAL ARTICLE
Determination of gouty arthritis' biomarkers in human
urine using reversed-phase high-performance
liquid chromatographyLei-Wen Xianga,b, Jing Lia, Jin-Ming Lina, Hai-Fang Lia,naBeijing Key Laboratory of Microanalysis Methods and Instrumentation, Department of Chemistry, Tsinghua University,
Beijing 100084, China
bInstitute of Food and Fermentation Industries, Fuqing Branch of Fujian Normal University, Fuqing 350300, China
Received 10 May 2013; accepted 30 November 2013
Available online 12 December 2013KEYWORDS
Gouty arthritis;
Creatinine;
Uric acid;
Hypoxanthine;
Xanthine;
High-performance liquid
chromatography’an Jiaotong Univer
16/j.jpha.2013.11.00
hor. Tel./fax: þ86 1
aifang@mail.tsingh
esponsibility of Xi'aAbstract Creatinine, uric acid, hypoxanthine and xanthine are important diagnostic biomarkers in
human urine for gouty arthritis or renal disease diacrisis. A simple method for simultaneous determination
of these biomarkers in urine based on reversed-phase high-performance liquid chromatography (RP-
HPLC) with ultraviolet (UV) detector was proposed. After pretreatment by dilution, centrifugation and
ﬁltration, the biomarkers in urine samples were separated by ODS-BP column by elution with methanol/
50 mM NaH2PO4 buffer solution at pH 5.26 (5:95). Good linearity between peak areas and concentrations
of standards was obtained for the biomarkers with correlation coefﬁcients in the range of 0.9957–0.9993.
The proposed analytical method has satisfactory repeatability (the recovery of data in a range of
creatinine, uric acid, hypoxanthine and xanthine was 93.49–97.90%, 95.38–96.45%, 112.46–115.78% and
90.82–97.13% with standard deviation ofo5%, respectively) and the limits of detection (LODs, S/NZ3)
for creatinine, uric acid, hypoxanthine, and xanthine were 0.010, 0.025, 0.050 and 0.025 mg/L,
respectively. The established method was proved to be simple, accurate, sensitive and reliable for the
quantitation of gouty arthritis' biomarkers in human urine samples. The ratio of creatinine to uric acid was
found to be a possible factor for assessment of gouty arthritis.
& 2014 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.sity. Production and hosting by Elsev
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In clinical diagnosis, the uric acid concentration in gouty arthritis
patients has been evaluated on (a) decreased destruction of uric acid,
(b) overproduction of uric acid, and (c) an abnormality in the kidney
excretion of uric acid [1]. Uric acid is the hepatic pro-
duct of purine metabolism. After primary ﬁltration by the kidney, the
metabolic uric acid is reabsorbed into the blood circulation system orier B.V. All rights reserved.
L.-W. Xiang et al.154secreted into the urine [2]. The symptoms of gouty might be abnormal
metabolism of kidney excretion of uric acid. In addition, creatinine is
one of the most widely used biomarkers of kidney function [3].
Therefore, the study of simultaneous determination of uric acid and
creatinine for diagnosis of gouty arthritis has been of importance.
The conventional method for the determination of these biomar-
kers in plasma and urine is based on the enzymatic conversion of
urate to allantoin using uricase followed by colorimetric measurement
[4,5]. However, this method includes unstable reagents and suffers
from interferences such as ascorbic acid and dopamine, which are
present in biological ﬂuids. In the past decades, different chromato-
graphic methods were applied to determine uric acid or uric acid and
creatinine, including ion-exchange liquid chromatography [6], paired-
ion liquid chromatography [7], size-exclusion liquid chromatography
[8], liquid chromatography/mass spectrometry [9–11], high-
performance liquid chromatography (HPLC) [5,12–19], column-
switching liquid chromatography [20], hydrophilic interaction chro-
matography [21] and capillary electrophoresis [22–27].
In human body, uric acid is the end-metabolic product of adenine
and guanine as shown in Fig. 1A. Adenine is catalyzed by adenase to
hypoxanthine, which is catalyzed by xanthine oxidase undergoing
xanthine and ﬁnally to uric acid. Xanthine can also be produced from
guanine by guanase catalysis [1]. Creatinine is excreted from creatine
and phosphocreatine and this process occurs at fractional rates of 0.016
and 0.03 per day for creatine and phosphocreatine, respectively. It leads
to the irreversible, non-enzymatic dehydration and loss of phosphate
from phosphocreatine as shown in Fig. 1B. The amount of creatinine in
the urine is proportional to the amount of creatine and creatine
phosphate present in the human body [28]. Creatinine is one of the
most widely used markers of renal function. Changes in urinary
creatinine content can indicate the renal problems [3]. Herein,
creatinine, uric acid, hypoxanthine and xanthine are important diag-
nostic biomarkers in human urine for gouty arthritis or renal disease.Fig. 1 Chemical structures of uric acid, cHowever, to the best of our knowledge, methods for simulta-
neous determination of uric acid, creatinine, xanthine and hypox-
anthine in urine still have not been reported. Sometimes the spot
concentration of uric acid does not represent the real level in the
body because of the effect of biological clock. The 24 h monitoring
uric acid is not applicable for clinical diagnosis. Therefore, the
combination of uric acid, creatinine, hypoxanthine and xanthine is
more instructional for correct and integrated diagnosis of gouty
arthritis. In our study, a chromatographic method for simultaneous
determination of these four biomarkers in urine was proposed.
A simple pretreatment to remove the protein interferents was
performed for real urine samples before chromatographic analysis.
The samples were pretreated by dilution, centrifugation and
ﬁltration, and then were analyzed with HPLC. Urine samples
from healthy and gouty volunteers were gathered. It was found in
this study that the ratio of creatinine to uric acid may be considered
as an additional assessment factor for diagnosis of gouty arthritis.2. Experimental
2.1. Chemicals and reagents
Creatinine, uric acid, hypoxanthine and xanthine were purchased
from Sigma-Aldrich (USA). Methanol supplied by J&K Scientiﬁc
Ltd. (USA) was of HPLC grade. Sodium dihydrogen phosphate
and sodium hydroxygen obtained from Beijing Chemical Reagent
Company (China) were used for preparing HPLC buffer solutions.
All chemicals were dissolved with de-ionized water.
Creatinine standard (200 mg/L) was freshly prepared in water.
Uric acid standard (200 mg/L) was dissolved in basic aqueous
solution at a pH value of 10.35 to increase the solubility.
Hypoxanthine and xanthine standards (200 mg/L, respectively)reatinine, hypoxanthine and xanthine.
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solutions of standards were prepared from the stock standard
solution. Calibration curves were prepared with the concentration
ranging from 5 to 200 mg/L for the standards.
2.2. Urine samples preparation
Urine samples were collected from healthy volunteers and patients
with gouty arthritis in plastic containers. Urine samples were
diluted 5-fold with HPLC mobile phase and the proteins were
precipitated by centrifugation at 6000 rpm for 10 min. The super-
natants of urine were diluted 3-fold with HPLC mobile phase to
facilitate. The pretreated samples were ﬁltered through a 0.45 μm
membrane for HPLC determination.
2.3. HPLC instrumentation and conditions
A Hitachi L-2000 high-performance liquid chromatography (Hitachi
Corporation, Japan) equipped with L-2130 pump, L-2300 column
oven, UV L-2400 spectrophotometer detector and D2000HSM
software was used for analysis. The analytical column used in
the experiments was a SinoChrom ODS-BP column (250 mm
4.6 mm, 5 μm). The mobile phase consisted of 5% methanol and
95% NaH2PO4 buffer solution (50 mM, pH 5.26) and the ﬂow
rate was 0.8 mL/min. The mobile phase solvents were ﬁltered
through a 0.45 μm membrane and degassed before use. The
sample detection was carried out at the 210 nm wavelength with
an injection volume of 20 μL.3. Result and discussion
3.1. Optimization of HPLC analysis
Creatinine, uric acid, hypoxanthine and xanthine are very polar
small molecules (see Fig. 1) showing very poor retention on ODS
columns. Because of proper carbon content, the SinoChrom ODS-BP
columns were suitable for the separation of the hydrophilic sample
containing a high proportion of water in the mobile phase
conditions with a strong retention. The concentrations of these
biomarkers are very different in human urine. The separation of
these biomarkers requires a highly aqueous mobile phase, which
causes the retention loss of the analytes on the reversed-phase
column, and equilibration of the column with an organic solvent
after each run. To verify the applicability of the analytical protocol,
the pH value and the composition of the HPLC mobile phase were
thoroughly optimized. The reproducibility of qualitative and quantita-
tive detection was evaluated.
For the better conditions of an analytical protocol, the mobile
phase should be either free from or have a low level of organic
solvents for the polar analytes. An eluent of modest elution
force with a certain pH value to keep the analytes in neutral
forms is required. Thus, organic/aqueous buffer solution was
tested as the mobile phase. The methanol/NaH2PO4 buffer
solution or methanol/NaAc buffer solution was tried as the
mobile phases. NaH2PO4 buffer solution (50 mM, pH 5.26) and
NaAc (20 mM, pH 7.40) were selected as the aqueous phase
according to the relevant literature [6,20]. Experimental results
showed that uric acid and creatinine could be baseline separated
by both mobile phases, but hypoxanthine and xanthine could
not be separated by methanol/NaAc mobile phase. Thus,methanol/NaH2PO4 eluent was the ﬁnal choice as the
mobile phase.
Organic phase ratio affected the retention time of biomarkers in
the ODS-BP column, organic phase ratio was selected as 5% and
10%. As shown in Fig. 2, experimental results showed that the
baseline separation of biomarkers could be achieved under the
ratio of methanol 10% and 5% (Fig. 2A and C). At the 10%
proportion of methanol, impurity peaks were close to targets as
shown in Fig. 2B. To ensure the separation effect of the actual
sample, the ultimate eluent was methanol/NaH2PO4 buffer solution
(5:95).
Considering the effect of detect wavelength on the detected
results, UV detection wavelength from 200 nm to 230 nm was
estimated. Experimental results illustrated that the detection
wavelength at 210 nm was good for the absorption of biomarkers.
The UV absorbance of creatinine, uric acid, hypoxanthine and
xanthine did not interfere with each other.
Based on a series of tests, the optimum separation and detection
conditions were achieved as isocratic elution program at 0.8 mL/
min ﬂow rate with an eluent of methanol/NaH2PO4 buffer solution
(5:95). The chromatogram for standards of creatinine, uric acid,
hypoxanthine and xanthine is shown in Fig. 2C. All biomarkers
gave sharp and symmetric peaks and were well separated within
12 min.
3.2. Linearity, sensitivity and precision of the analysis method
The real urine sample of a volunteer was pretreated and deter-
mined. As shown in Fig. 2D, creatinine, uric acid, hypoxanthine
and xanthine were found. Compared with uric acid and creatinine,
hypoxanthine and xanthine presented a lower level in human
urine. The relative standard deviation (RSD) values of the
retention times were smaller than 1.3% (the real urine sample of
a volunteer was replicated six times and gained RSD by calculat-
ing), indicating that the developed separation method was stable
enough.
A series of standard solutions over different concentration
ranges for each analyte was detected for calibration curves. The
quantitative performance factors are listed in Table 1. The LODs
(signal/noise ratio [S/N]Z3) were 0.010 mg/L for creatinine,
0.025 mg/L for uric acid, 0.050 mg/L for hypoxanthine and
0.025 mg/L for xanthine. The accuracy of the method was
estimated by adding two levels of standards for each target to
the urine sample. The recoveries of targets were in the range of
90.82–115.78% as listed in Table 2.
3.3. Application to assess of gouty arthritis
Urine samples from 16 volunteers were analyzed using the
developed RP-HPLC method discussed above. Results are listed
in Table 3. The concentrations of creatinine, uric acid, hypox-
anthine and xanthine for the gouty group were in the range of
1086–2316 mg/L, 587–1163 mg/L, 79–150 mg/L and 25–90 mg/L,
respectively. However, the concentrations of creatinine, uric acid,
hypoxanthine and xanthine for the healthy group were in the range
of 194–1621 mg/L, 52–553 mg/L, 15–156 mg/L and 25–171 mg/L,
respectively. It could be seen that the concentration levels of
creatinine and uric acid in the gouty group were much higher than
those in the healthy group. However, compared with the healthy
group, the concentration of xanthine and hypoxanthine for the
gouty group changed slightly.
Table 1 Linearity of analytical method.
Constituents Retention time (min) Parameters of linear regression Range of linearity (mg/L) r2
Creatinine 5.14 Y¼94632Xþ94219 10–200 0.9993
Uric acid 7.41 Y¼89899Xþ274915 7.5–150 0.9957
Hypoxanthine 10.00 Y¼106554Xþ18426 5–100 0.9999
Xanthine 11.61 Y¼111030X25303 5–100 0.9994
Fig. 2 Effect of the ratio of organic phase. (The ﬂow rate was 0.8 mL/min, the column temperature was 25 1C, the UV detection wavelength was
210 nm, and the injection volume was 20 μL. 1, 2, 3 and 4 stand for creatinine, uric acid, hypoxanthine and xanthine, respectively. A and C are
mixed standard while B and D are actual urine sample. The HPLC mobile phases were methanol/NaH2PO4 buffer solution (10:90) and methanol/
NaH2PO4 buffer solution (5:95)).
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targets' concentration at different biological clocks. Urine samples
of healthy individuals were collected at the interval of 2 h from
6:00 to 24:00 and last for three days. As shown in Fig. 3, the
concentrations of biomarkers changed with time. But the concen-
trations of creatinine and uric acid signiﬁcantly changed. In the
morning, the concentrations of creatinine and uric acid were high
because the two biomarkers were accumulated during sleep. When
the volunteer stayed hungry (near 12:00 and 18:00), the concen-
trations of creatinine and uric acid increased. And the concentra-
tions of biomarkers were different under various conditions. For
examples, the daily food, high levels of purine foods especially,
affects the concentration of biomarkers in human urine. Theconsumption of cranberry fruit juice has an effect on the
concentration of urinary uric acid [21]. The ingestion of Tofu
(bean curd) would increase the plasma concentration of uric acid,
together with increasing uric acid clearance and urinary excretion
of uric acid. The increase of uric acid in plasma concentration was
very small [29]. Therefore, the point concentration of biomarkers
was not ﬁt to be a reliable index for screening test of gouty arthritis
assessment.
In our study, the ratio of creatinine to uric acid was found to be
a possible factor for assessment of gouty arthritis. As presented in
Table 3, the value of uric acid No. 12 in the healthy group was
553.37 mg/L, nearly 600 mg/L. However, the ratio of creatinine to
uric acid was 2.26, beyond 2.0. In Table 3, the ratio of creatinine
Table 3 Analytical results of creatinine, uric acid, hypoxanthine and xanthine in the human urine sample.
Urine
sample
Creatinine
(mg/L)
Uric acid
(mg/L)
Hypoxanthine
(mg/L)
Xanthine
(mg/L)
Ratio of
creatinine
to uric acid
Gouty group
1 2316.31 1163.22 150.24 85.54 1.99
2 1731.57 1146.86 125.89 72.21 1.51
3 1622.91 1069.85 91.94 25.17 1.52
4 1057.32 719.82 100.78 90.55 1.47
5 1314.07 874.40 79.59 59.64 1.50
6 1086.87 587.47 80.28 90.66 1.85
Healthy group
7 861.25 411.78 51.96 62.88 2.09
8 1521.93 388.97 55.83 54.44 3.91
9 463.63 177.85 15.95 39.10 2.61
10 1621.70 390.32 30.99 32.60 4.15
11 659.74 321.80 61.43 29.24 2.05
12 1248.28 553.37 145.52 64.06 2.26
13 194.90 52.84 57.04 25.15 3.69
14 665.17 223.70 156.60 135.55 2.97
15 1291.88 454.14 66.16 171.03 2.84
16 568.61 173.48 133.50 121.81 3.28
Fig. 3 A time course of the concentration of creatinine, uric acid,
hypoxanthine and xanthine in human urine.
Table 2 The recoveries and the detection limit of creatinine, uric acid, hypoxanthine and xanthine in the human urine sample.
Analysts Actual concentration of
sample (mg/L)
Standard addeda
(mg/L)
Mean recoveryb
(%)7SD
LOD
(mg/L)
Creatinine 861.25 160 97.9070.84 0.010
320 93.4970.79
Uric acid 411.78 80 96.4574.20 0.025
160 95.3871.76
Hypoxanthine 51.96 50 112.4671.08 0.050
100 115.7870.94
Xanthine 54.44 20 97.1373.16 0.025
50 90.8270.96
aConcentrations of standards are expressed as the equivalent concentrations added in the ﬁnal injected solutions. Each level of standard added was
replicated six times.
bCalculated recovery (%)¼ (amount observedoriginal amount)/added amount 100%.
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However, the value of uric acid was 1163.22 mg/L. Hence, only
the values of uric acid at 600 mg/L might not be an accurate value
for diagnosis. It appears that the ratio of creatinine to uric acid
together with considering the values of uric acid could be used as a
clinical assessment of gouty arthritis.4. Conclusions
A simple and reliable RP-HPLC method has been developed for
simultaneous determination of creatinine, uric acid, hypoxanthine
and xanthine in human urine. It has a simple pretreated procedure
and a relatively short detection time. The developed method has
been successfully applied to determine urine samples from healthy
and gouty volunteers. The ratio of creatinine to uric acid was
found to be a possible factor for assessment of gouty arthritis.
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